help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lledo, P. M.
Right arrow Articles by Vincent, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lledo, P. M.
Right arrow Articles by Vincent, J. D.

Endocrinology, Vol 127, 990-1001, Copyright © 1990 by Endocrine Society


ARTICLES

Dopamine inhibits two characterized voltage-dependent calcium currents in identified rat lactotroph cells

PM Lledo, P Legendre, JM Israel and JD Vincent
INSERM U.176, 33077 Bordeaux, France.

The effects of dopamine (DA) on voltage-dependent Ca2+ currents were investigated in cultured rat lactotroph cells using the patch clamp recording technique. Each recorded cell was identified by the reverse hemolytic plaque assay. In the whole-cell configuration, two types of Ca2+ currents, L and T, were characterized on the basis of their kinetics, voltage sensitivity, and pharmacology. The L component had a threshold of -25 mV, showed little inactivation during a 150-msec voltage step, and was maximal at +10 mV. Cadmium ions (100 microM) significantly reduced its amplitude (75%). The T component was activated at a membrane potential close to -50 mV, was maximal at -10 mV, and showed a voltage-dependent inactivation between -90 and -30 mV. It was quickly inactivated during a maintained depolarization (time constant, 27 ms at -30 mV) and was strongly reduced (80%) by nickel ions (100 microM). Bath application of DA (10 nM) caused a markedly general depression of inward Ca2+ currents, acting differently on the T- and L-type currents. DA application shifted the voltage-dependence of the L-type current activation toward depolarization values (8 mV) without modifying its time- and voltage-dependent inactivation. In contrast, DA enhanced the inactivation of the T-type current by accelerating its time-dependent inactivation (25% decrease in the time constant of inactivation) and by shifting the voltage-dependence of the T-type current inactivation toward hyperpolarizing values (-63 mV in control vs. -77 mV in the presence of DA). These effects of DA were dose-dependent and involved the activation of a D2 receptor type. They were mimicked by bromocriptine application (10 nM), whereas sulpiride (100 nM) blocked the DA-evoked response. The D1 antagonist SCH 23390 was ineffective up to 100 microM. All of these DA-induced modifications in Ca2+ currents were abolished using a GTP-free pipette solution or after pretreatment of cells with pertussis toxin, suggesting that DA can regulate the function of Ca2+ channels through GTP-binding proteins (G-proteins). Our results show that DA acts simultaneously by reducing both voltage-dependent Ca2+ currents on lactotroph cells. Thus, DA reduces the entry of Ca2+ ions across the surface membrane and thereby influences electrical activity and the cytosolic free Ca2+ concentration involved in both basal and evoked PRL release.


This article has been cited by other articles:


Home page
EndocrinologyHome page
A. E. Gonzalez-Iglesias, T. Murano, S. Li, M. Tomic, and S. S. Stojilkovic
Dopamine Inhibits Basal Prolactin Release in Pituitary Lactotrophs through Pertussis Toxin-Sensitive and -Insensitive Signaling Pathways
Endocrinology, April 1, 2008; 149(4): 1470 - 1479.
[Abstract] [Full Text] [PDF]


Home page
Neural Comput.Home page
N. Toporikova, J. Tabak, M. E. Freeman, and R. Bertram
A-Type K+ Current Can Act as a Trigger for Bursting in the Absence of a Slow Variable
Neural Comput., February 1, 2008; 20(2): 436 - 451.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
M. F. Lopez-Aranda, M. J. Acevedo, A. Gutierrez, P. Koulen, and Z. U. Khan
Role of a G{alpha}i2 protein splice variant in the formation of an intracellular dopamine D2 receptor pool
J. Cell Sci., July 1, 2007; 120(13): 2171 - 2178.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
E. Perez-Reyes
Molecular Physiology of Low-Voltage-Activated T-type Calcium Channels
Physiol Rev, January 1, 2003; 83(1): 117 - 161.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
B. Banihashemi and P. R. Albert
Dopamine-D2S Receptor Inhibition of Calcium Influx, Adenylyl Cyclase, and Mitogen-Activated Protein Kinase in Pituitary Cells: Distinct G{alpha} and G{beta}{gamma} Requirements
Mol. Endocrinol., October 1, 2002; 16(10): 2393 - 2404.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
N. Ben-Jonathan and R. Hnasko
Dopamine as a Prolactin (PRL) Inhibitor
Endocr. Rev., December 1, 2001; 22(6): 724 - 763.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
M. E. Freeman, B. Kanyicska, A. Lerant, and G. Nagy
Prolactin: Structure, Function, and Regulation of Secretion
Physiol Rev, October 1, 2000; 80(4): 1523 - 1631.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
P. Kloppenburg, W. R. Zipfel, W. W. Webb, and R. M. Harris-Warrick
Highly Localized Ca2+ Accumulation Revealed by Multiphoton Microscopy in an Identified Motoneuron and Its Modulation by Dopamine
J. Neurosci., April 1, 2000; 20(7): 2523 - 2533.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Q. Gu, K. S. Korach, and R. L. Moss
Rapid Action of 17{beta}-Estradiol on Kainate-Induced Currents in Hippocampal Neurons Lacking Intracellular Estrogen Receptors
Endocrinology, February 1, 1999; 140(2): 660 - 666.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
K. Tanaka, I. Shibuya, N. Kabashima, Y. Ueta, and H. Yamashita
Inhibition of Voltage-Dependent Calcium Channels by Prostaglandin E2 in Rat Melanotrophs
Endocrinology, December 1, 1998; 139(12): 4801 - 4810.
[Abstract] [Full Text] [PDF]


Home page
J PsychopharmacolHome page
M. R. Bennett
Monoaminergic synapses and schizophrenia: 45 years of neuroleptics
J Psychopharmacol, January 1, 1998; 12(3): 289 - 304.
[Abstract] [PDF]


Home page
Physiol. Rev.Home page
C. MISSALE, S. R. NASH, S. W. ROBINSON, M. JABER, and M. G. CARON
Dopamine Receptors: From Structure to Function
Physiol Rev, January 1, 1998; 78(1): 189 - 225.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
A. B. Belousov and A. N. V. D. Pol
Dopamine Inhibition: Enhancement of GABA Activity and Potassium Channel Activation in Hypothalamic and Arcuate Nucleus Neurons
J Neurophysiol, August 1, 1997; 78(2): 674 - 688.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1990 by The Endocrine Society